Englemed is a specialist on-line news agency. We have provided feeds of medical and health news for 16 years to a range of customers. Our major client is currently Doctors_net_uk, the leading social media site for doctors. If you are interested in developing a specialist news service, please contact us. Although our business is mainly with professional clients, our background is in news and we can produce newsfeeds in plain English for a lay audience.
Coffee compounds could inhibit prostate cancer - lab study
Monday March 18th, 2019
Compounds found in coffee could inhibit prostate cancer, a European conference is to hear today.
A pilot study, carried out on drug-resistant cancer cells in cell culture and in a mouse model,
found that cells treated with two compounds – kahweol acetate and cafestol – grew
more slowly than controls.
Researchers tested the compounds on prostate cancer cells that had been transplanted to mice – four were treated with kahweol acetate, four with cafestol, four with a combination of kahweol acetate and cafestol, and four were controls.
Atrial fibrillation sub-types defined
Monday March 18th, 2019
Individualised treatment for people with atrial fibrillation is a step closer, thanks to the discovery of subtypes of the heart disorder, a conference has heard. More
Painkillers in pregnancy not cause of asthma
Monday March 18th, 2019
Taking paracetamol or other painkillers during pregnancy does not cause asthma in the offspring – but may indicate other factors increasing the risk, according to a large-scale study out today. More
Gynaecologists to tackle fertility confusion
Coffee compounds could inhibit prostate cancer - lab study
Air pollution threat measured
Extend anti-hypertensive medication - guidance